Contrariwise, suppression of NF-κB activation decreases acute inflammatory responses and organ dysfunction outcome [29] and down-regulation of NF-κB activation could be a suitable therapeutic target in sepsis. The gene discussed is NFKB1; the disease is Sepsis.